15. OPEN LABEL, RANDOMIZED, ACTIVE DRUG COMPARATIVE, PARALLEL GROUP, MULTI-CENTER, PHASE IV STUDY TO COMPARE THE EFFECT OF BENIDIPINE AND LOSARTAN ON ARTERIAL STIFFNESS AND CENTRAL BLOOD PRESSURE IN MILD TO MODERATE ESSENTIAL HYPERTENSIVE PATIENTS (BELASCO TRIAL)

Objectives: The purpose of this study was to compare the effect of benidipine (calcium channel blocker) and losartan (angiotensin receptor blocker) on arterial stiffness and central blood pressure (BP) in mild to moderate essential hypertensives. Methods and Results: This 24 weeks, multi-center, op...

Full description

Bibliographic Details
Main Authors: Sang-Hyun Ihm, Shung Chull Chae, Do Sun Lim, Kee Sik Kim, Dong Ju Choi, Jong Won Ha, Dong Soo Kim, Kye Hun Kim, Myeong Chan Cho, Hui Kyung Jeon, Sang Hong Baek
Format: Article
Language:English
Published: Atlantis Press 2009-10-01
Series:Artery Research
Online Access:https://www.atlantis-press.com/article/125925809/view
id doaj-7b9b906746294c8e9b05236ae922fe13
record_format Article
spelling doaj-7b9b906746294c8e9b05236ae922fe132020-11-25T03:00:57ZengAtlantis PressArtery Research 1876-44012009-10-013310.1016/j.artres.2009.06.02915. OPEN LABEL, RANDOMIZED, ACTIVE DRUG COMPARATIVE, PARALLEL GROUP, MULTI-CENTER, PHASE IV STUDY TO COMPARE THE EFFECT OF BENIDIPINE AND LOSARTAN ON ARTERIAL STIFFNESS AND CENTRAL BLOOD PRESSURE IN MILD TO MODERATE ESSENTIAL HYPERTENSIVE PATIENTS (BELASCO TRIAL)Sang-Hyun IhmShung Chull ChaeDo Sun LimKee Sik KimDong Ju ChoiJong Won HaDong Soo KimKye Hun KimMyeong Chan ChoHui Kyung JeonSang Hong BaekObjectives: The purpose of this study was to compare the effect of benidipine (calcium channel blocker) and losartan (angiotensin receptor blocker) on arterial stiffness and central blood pressure (BP) in mild to moderate essential hypertensives. Methods and Results: This 24 weeks, multi-center, open label, randomized, active drug comparative, parallel group study was designed as a noninferior study. Eligible patients (n=200) were randomly assigned to receive benidipine (n=101) or losartan (n=99). Radial artery applanation tonometry and pulse wave analysis were used to derive central aortic pressure, pulse wave velocity (PWV) and augmentation index (AIx). No significant differences were found in the mean changes in central BP between 2 groups [−16.66 (systolic BP)/−10.70 (diastolic BP) mmHg in the benidipine group and –18.44/−11.79 mmHg in the losartan group; P=NS]. The mean changes in central, brachial and femoral PWV were –0.06, +0.06 and −0.51m/sec for the benidipine group and −0.02, −0.15 and −0.06m/s for losartan group (respectively; P=NS). No significant differences were found in the mean changes in AIx between two groups [−5.46 in the benidipine group and −4.22 in the losartan group; P=NS]. Conclusion: The reduction in central BP after 24 weeks of benidipine was non-inferior to that of losartan in mild to moderate essential hypertensives. There were no significant different between two drugs in aspect of PWV and AIx. Both drugs had similar central BP lowering effect and affected similarly arterial stiffness.https://www.atlantis-press.com/article/125925809/view
collection DOAJ
language English
format Article
sources DOAJ
author Sang-Hyun Ihm
Shung Chull Chae
Do Sun Lim
Kee Sik Kim
Dong Ju Choi
Jong Won Ha
Dong Soo Kim
Kye Hun Kim
Myeong Chan Cho
Hui Kyung Jeon
Sang Hong Baek
spellingShingle Sang-Hyun Ihm
Shung Chull Chae
Do Sun Lim
Kee Sik Kim
Dong Ju Choi
Jong Won Ha
Dong Soo Kim
Kye Hun Kim
Myeong Chan Cho
Hui Kyung Jeon
Sang Hong Baek
15. OPEN LABEL, RANDOMIZED, ACTIVE DRUG COMPARATIVE, PARALLEL GROUP, MULTI-CENTER, PHASE IV STUDY TO COMPARE THE EFFECT OF BENIDIPINE AND LOSARTAN ON ARTERIAL STIFFNESS AND CENTRAL BLOOD PRESSURE IN MILD TO MODERATE ESSENTIAL HYPERTENSIVE PATIENTS (BELASCO TRIAL)
Artery Research
author_facet Sang-Hyun Ihm
Shung Chull Chae
Do Sun Lim
Kee Sik Kim
Dong Ju Choi
Jong Won Ha
Dong Soo Kim
Kye Hun Kim
Myeong Chan Cho
Hui Kyung Jeon
Sang Hong Baek
author_sort Sang-Hyun Ihm
title 15. OPEN LABEL, RANDOMIZED, ACTIVE DRUG COMPARATIVE, PARALLEL GROUP, MULTI-CENTER, PHASE IV STUDY TO COMPARE THE EFFECT OF BENIDIPINE AND LOSARTAN ON ARTERIAL STIFFNESS AND CENTRAL BLOOD PRESSURE IN MILD TO MODERATE ESSENTIAL HYPERTENSIVE PATIENTS (BELASCO TRIAL)
title_short 15. OPEN LABEL, RANDOMIZED, ACTIVE DRUG COMPARATIVE, PARALLEL GROUP, MULTI-CENTER, PHASE IV STUDY TO COMPARE THE EFFECT OF BENIDIPINE AND LOSARTAN ON ARTERIAL STIFFNESS AND CENTRAL BLOOD PRESSURE IN MILD TO MODERATE ESSENTIAL HYPERTENSIVE PATIENTS (BELASCO TRIAL)
title_full 15. OPEN LABEL, RANDOMIZED, ACTIVE DRUG COMPARATIVE, PARALLEL GROUP, MULTI-CENTER, PHASE IV STUDY TO COMPARE THE EFFECT OF BENIDIPINE AND LOSARTAN ON ARTERIAL STIFFNESS AND CENTRAL BLOOD PRESSURE IN MILD TO MODERATE ESSENTIAL HYPERTENSIVE PATIENTS (BELASCO TRIAL)
title_fullStr 15. OPEN LABEL, RANDOMIZED, ACTIVE DRUG COMPARATIVE, PARALLEL GROUP, MULTI-CENTER, PHASE IV STUDY TO COMPARE THE EFFECT OF BENIDIPINE AND LOSARTAN ON ARTERIAL STIFFNESS AND CENTRAL BLOOD PRESSURE IN MILD TO MODERATE ESSENTIAL HYPERTENSIVE PATIENTS (BELASCO TRIAL)
title_full_unstemmed 15. OPEN LABEL, RANDOMIZED, ACTIVE DRUG COMPARATIVE, PARALLEL GROUP, MULTI-CENTER, PHASE IV STUDY TO COMPARE THE EFFECT OF BENIDIPINE AND LOSARTAN ON ARTERIAL STIFFNESS AND CENTRAL BLOOD PRESSURE IN MILD TO MODERATE ESSENTIAL HYPERTENSIVE PATIENTS (BELASCO TRIAL)
title_sort 15. open label, randomized, active drug comparative, parallel group, multi-center, phase iv study to compare the effect of benidipine and losartan on arterial stiffness and central blood pressure in mild to moderate essential hypertensive patients (belasco trial)
publisher Atlantis Press
series Artery Research
issn 1876-4401
publishDate 2009-10-01
description Objectives: The purpose of this study was to compare the effect of benidipine (calcium channel blocker) and losartan (angiotensin receptor blocker) on arterial stiffness and central blood pressure (BP) in mild to moderate essential hypertensives. Methods and Results: This 24 weeks, multi-center, open label, randomized, active drug comparative, parallel group study was designed as a noninferior study. Eligible patients (n=200) were randomly assigned to receive benidipine (n=101) or losartan (n=99). Radial artery applanation tonometry and pulse wave analysis were used to derive central aortic pressure, pulse wave velocity (PWV) and augmentation index (AIx). No significant differences were found in the mean changes in central BP between 2 groups [−16.66 (systolic BP)/−10.70 (diastolic BP) mmHg in the benidipine group and –18.44/−11.79 mmHg in the losartan group; P=NS]. The mean changes in central, brachial and femoral PWV were –0.06, +0.06 and −0.51m/sec for the benidipine group and −0.02, −0.15 and −0.06m/s for losartan group (respectively; P=NS). No significant differences were found in the mean changes in AIx between two groups [−5.46 in the benidipine group and −4.22 in the losartan group; P=NS]. Conclusion: The reduction in central BP after 24 weeks of benidipine was non-inferior to that of losartan in mild to moderate essential hypertensives. There were no significant different between two drugs in aspect of PWV and AIx. Both drugs had similar central BP lowering effect and affected similarly arterial stiffness.
url https://www.atlantis-press.com/article/125925809/view
work_keys_str_mv AT sanghyunihm 15openlabelrandomizedactivedrugcomparativeparallelgroupmulticenterphaseivstudytocomparetheeffectofbenidipineandlosartanonarterialstiffnessandcentralbloodpressureinmildtomoderateessentialhypertensivepatientsbelascotrial
AT shungchullchae 15openlabelrandomizedactivedrugcomparativeparallelgroupmulticenterphaseivstudytocomparetheeffectofbenidipineandlosartanonarterialstiffnessandcentralbloodpressureinmildtomoderateessentialhypertensivepatientsbelascotrial
AT dosunlim 15openlabelrandomizedactivedrugcomparativeparallelgroupmulticenterphaseivstudytocomparetheeffectofbenidipineandlosartanonarterialstiffnessandcentralbloodpressureinmildtomoderateessentialhypertensivepatientsbelascotrial
AT keesikkim 15openlabelrandomizedactivedrugcomparativeparallelgroupmulticenterphaseivstudytocomparetheeffectofbenidipineandlosartanonarterialstiffnessandcentralbloodpressureinmildtomoderateessentialhypertensivepatientsbelascotrial
AT dongjuchoi 15openlabelrandomizedactivedrugcomparativeparallelgroupmulticenterphaseivstudytocomparetheeffectofbenidipineandlosartanonarterialstiffnessandcentralbloodpressureinmildtomoderateessentialhypertensivepatientsbelascotrial
AT jongwonha 15openlabelrandomizedactivedrugcomparativeparallelgroupmulticenterphaseivstudytocomparetheeffectofbenidipineandlosartanonarterialstiffnessandcentralbloodpressureinmildtomoderateessentialhypertensivepatientsbelascotrial
AT dongsookim 15openlabelrandomizedactivedrugcomparativeparallelgroupmulticenterphaseivstudytocomparetheeffectofbenidipineandlosartanonarterialstiffnessandcentralbloodpressureinmildtomoderateessentialhypertensivepatientsbelascotrial
AT kyehunkim 15openlabelrandomizedactivedrugcomparativeparallelgroupmulticenterphaseivstudytocomparetheeffectofbenidipineandlosartanonarterialstiffnessandcentralbloodpressureinmildtomoderateessentialhypertensivepatientsbelascotrial
AT myeongchancho 15openlabelrandomizedactivedrugcomparativeparallelgroupmulticenterphaseivstudytocomparetheeffectofbenidipineandlosartanonarterialstiffnessandcentralbloodpressureinmildtomoderateessentialhypertensivepatientsbelascotrial
AT huikyungjeon 15openlabelrandomizedactivedrugcomparativeparallelgroupmulticenterphaseivstudytocomparetheeffectofbenidipineandlosartanonarterialstiffnessandcentralbloodpressureinmildtomoderateessentialhypertensivepatientsbelascotrial
AT sanghongbaek 15openlabelrandomizedactivedrugcomparativeparallelgroupmulticenterphaseivstudytocomparetheeffectofbenidipineandlosartanonarterialstiffnessandcentralbloodpressureinmildtomoderateessentialhypertensivepatientsbelascotrial
_version_ 1724695801540640768